Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for Windows
Did you mean: ( Michel syndrome)?
(Marchiafava Micheli syndrome)
4,046 results
  • Pediatric Hepatic Venous Outflow Tract Obstruction: Experience from a Transplant Center. [Journal Article]
    Indian Pediatr 2019; 56(11):965-967Malik I, Bhatia V, … Goyal N
  • We performed a review of case records of children diagnosed with hepatic venous outflow tract obstruction at our center in last 10 years. Out of 11 cases identified, 6 had variable blocks in the hepatic venous system and 4 had combined hepatic venous and inferior vena cava (IVC) block. One child with paroxysmal nocturnal hemoglobinuria (PNH) had isolated IVC involvement. Angioplasty was attempted…
  • Paroxysmal Cold Hemoglobinuria in a 4-year-old Child. [Journal Article]
    Indian Pediatr 2019; 56(10):879-880Naithani R, Jeyaraman P, … Pathak S
  • Paroxysmal Cold Hemoglobinuria is a rare cause of intravascular hemolysis presenting in children following an acute viral illness. It is usually self-limiting in nature. We present the details of a 4-year-old boy who presented with rapid onset intravascular hemolysis. Donath Landsteiner antibody test was positive and hemolysis resolved within two weeks of onset.
  • Analysis of platelets by flow cytometry in patients with Paroxysmal Nocturnal Hemoglobinuria (PNH). [Journal Article]
    Blood Cells Mol Dis 2020; 80:102372Araten DJ, Boxer D, … Nardi M
  • The marked pro-thrombotic tendency in PNH is likely to be at least partly due to the population of platelets derived from the abnormal stem cell clone. However, identification of GPI (-) platelets by flow cytometry can be technically difficult. Here we describe a technique that involves the addition of aspirin immediately after the separation of platelet rich plasma and the use of gel filtration …
  • Eculizumab and Beyond: The Past, Present, and Future of Complement Therapeutics. [Review]
    Transfus Med Rev 2019Patriquin CJ, Kuo KHM
  • Dysregulation of the complement system underlies the pathophysiology of many diseases. Renewed interest in complement occurred with the recognition that its therapeutic inhibition was possible. Terminal complement blockade with the anti-C5 monoclonal antibody eculizumab significantly changed management and clinical outcomes of patients with paroxysmal nocturnal hemoglobinuria, and served as a pro…
New Search Next